Morning After Tablet
Product Images NDC 69953-516

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Morning After (NDC 69953-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rapha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ma516 (Fda Spl Filing 516)

Packaging label for Morning After Levonorgestrel Tablet 1.5 mg by Rapha Pharmaceuticals, Inc. The label states it is an emergency contraceptive with one tablet per package. It highlights key usage notes such as taking it within 72 hours after unprotected sex and includes a Drug Facts panel with directions and active ingredient information. The label includes a barcode and manufacturer details.*

FDA Label Image

Ma517 (Fda Spl Filing 517)

Packaging label for Morning After Levonorgestrel Tablet 1.5 mg, an emergency contraceptive by Rapha Pharmaceuticals, Inc. The label states it contains one tablet, reduces pregnancy chance after unprotected sex, and is not for regular birth control. Directions, warnings, ingredients, and contact information are included on the sides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.